Skip to main content
A

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,282 across all filing types
Latest filing 2025-01-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于开展外汇套期保值业务的可行性分析报告
Regulatory Filings
2025-01-21 Chinese
独立董事提名人声明与承诺-乔海灵
Regulatory Filings
2025-01-21 Chinese
安图生物关于召开2025年第一次临时股东大会的通知
Regulatory Filings
2025-01-21 Chinese
安图生物关于以集中竞价交易方式回购公司股份的进展公告
Regulatory Filings
2025-01-02 Chinese
安图生物关于公司及全资子公司获得医疗器械注册证的公告
Regulatory Filings
2024-12-26 Chinese
安图生物关于完成工商变更登记的公告
Regulatory Filings
2024-12-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.